These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34158411)

  • 1. Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England.
    Knock ES; Whittles LK; Lees JA; Perez-Guzman PN; Verity R; FitzJohn RG; Gaythorpe KAM; Imai N; Hinsley W; Okell LC; Rosello A; Kantas N; Walters CE; Bhatia S; Watson OJ; Whittaker C; Cattarino L; Boonyasiri A; Djaafara BA; Fraser K; Fu H; Wang H; Xi X; Donnelly CA; Jauneikaite E; Laydon DJ; White PJ; Ghani AC; Ferguson NM; Cori A; Baguelin M
    Sci Transl Med; 2021 Jul; 13(602):. PubMed ID: 34158411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of tiered restrictions and a second lockdown with COVID-19 deaths and hospital admissions in England: a modelling study.
    Davies NG; Barnard RC; Jarvis CI; Russell TW; Semple MG; Jit M; Edmunds WJ; ;
    Lancet Infect Dis; 2021 Apr; 21(4):482-492. PubMed ID: 33357518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological drivers of transmissibility and severity of SARS-CoV-2 in England.
    Perez-Guzman PN; Knock E; Imai N; Rawson T; Elmaci Y; Alcada J; Whittles LK; Thekke Kanapram D; Sonabend R; Gaythorpe KAM; Hinsley W; FitzJohn RG; Volz E; Verity R; Ferguson NM; Cori A; Baguelin M
    Nat Commun; 2023 Jul; 14(1):4279. PubMed ID: 37460537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada.
    Ng V; Fazil A; Waddell LA; Bancej C; Turgeon P; Otten A; Atchessi N; Ogden NH
    CMAJ; 2020 Sep; 192(37):E1053-E1064. PubMed ID: 32778573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021.
    Tran TN; Wikle NB; Yang F; Inam H; Leighow S; Gentilesco B; Chan P; Albert E; Strong ER; Pritchard JR; Hanage WP; Hanks EM; Crawford FW; Boni MF
    JAMA Netw Open; 2022 May; 5(5):e2214171. PubMed ID: 35616938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.
    Chadeau-Hyam M; Wang H; Eales O; Haw D; Bodinier B; Whitaker M; Walters CE; Ainslie KEC; Atchison C; Fronterre C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Cooke G; Ward H; Darzi A; Riley S; Donnelly CA; Elliott P;
    Lancet Respir Med; 2022 Apr; 10(4):355-366. PubMed ID: 35085490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the COVID-19 epidemic trajectory and hospital capacity requirements in South West England: a mathematical modelling framework.
    Booton RD; MacGregor L; Vass L; Looker KJ; Hyams C; Bright PD; Harding I; Lazarus R; Hamilton F; Lawson D; Danon L; Pratt A; Wood R; Brooks-Pollock E; Turner KME
    BMJ Open; 2021 Jan; 11(1):e041536. PubMed ID: 33414147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.
    Ward T; Glaser A; Overton CE; Carpenter B; Gent N; Seale AC
    Epidemiol Infect; 2022 Dec; 151():e32. PubMed ID: 36535802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of public health interventions during the first epidemic wave of COVID-19 in Cyprus: a modelling study.
    Gountas I; Quattrocchi A; Mamais I; Tsioutis C; Christaki E; Fokianos K; Nikolopoulos G
    BMC Public Health; 2021 Oct; 21(1):1898. PubMed ID: 34666740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.
    Brooks-Pollock E; Northstone K; Pellis L; Scarabel F; Thomas A; Nixon E; Matthews DA; Bowyer V; Garcia MP; Steves CJ; Timpson NJ; Danon L
    BMC Med; 2023 Jan; 21(1):25. PubMed ID: 36658548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England.
    Ward T; Fyles M; Glaser A; Paton RS; Ferguson W; Overton CE
    Nat Commun; 2024 May; 15(1):4633. PubMed ID: 38821930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time nowcasting and forecasting of COVID-19 dynamics in England: the first wave.
    Birrell P; Blake J; van Leeuwen E; Gent N; De Angelis D
    Philos Trans R Soc Lond B Biol Sci; 2021 Jul; 376(1829):20200279. PubMed ID: 34053254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    Hauser A; Counotte MJ; Margossian CC; Konstantinoudis G; Low N; Althaus CL; Riou J
    PLoS Med; 2020 Jul; 17(7):e1003189. PubMed ID: 32722715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.
    Moghadas SM; Vilches TN; Zhang K; Wells CR; Shoukat A; Singer BH; Meyers LA; Neuzil KM; Langley JM; Fitzpatrick MC; Galvani AP
    Clin Infect Dis; 2021 Dec; 73(12):2257-2264. PubMed ID: 33515252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England.
    Elliott P; Eales O; Bodinier B; Tang D; Wang H; Jonnerby J; Haw D; Elliott J; Whitaker M; Walters CE; Atchison C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Ward H; Darzi A; Cooke GS; Chadeau-Hyam M; Donnelly CA
    Nat Commun; 2022 Aug; 13(1):4500. PubMed ID: 35922409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England.
    Keeling MJ; Moore S; Penman BS; Hill EM
    Nat Commun; 2023 Feb; 14(1):740. PubMed ID: 36765050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model.
    Pople D; Monk EJM; Evans S; Foulkes S; Islam J; Wellington E; Atti A; Hope R; Robotham J; Hopkins S; Brown CS; Hall VJ;
    BMJ; 2022 Jul; 378():e070379. PubMed ID: 35858689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City, China, January-February, 2020.
    Mizumoto K; Kagaya K; Chowell G
    BMC Med; 2020 Jul; 18(1):217. PubMed ID: 32664866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England.
    Mensah AA; Sinnathamby M; Zaidi A; Coughlan L; Simmons R; Ismail SA; Ramsay ME; Saliba V; Ladhani SN
    J Infect; 2021 Apr; 82(4):67-74. PubMed ID: 33639175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.